Condom Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Gender (Male, Female), By Type (Latex Condom, Non-Latex Condom), By Distribution Channel (Supermarkets/Hypermarkets, Drug/Pharmacy Stores, Convenience Stores, Online, Others (Departmental Stores, etc.)), By Region, By Competition Forecast & Opportunities 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 12.22 Billion
CAGR (2026-2031)	8.84%
Fastest Growing Segment	Latex Condom
Largest Market	Asia Pacific
Market Size (2031)	USD 20.31 Billion

Market Overview

The Global Condom Market will grow from USD 12.22 Billion in 2025 to USD 20.31 Billion by 2031 at a 8.84% CAGR. A condom is a sheath-shaped barrier device, typically manufactured from latex or polyurethane, used during sexual intercourse to reduce the probability of unintended pregnancy and prevent the transmission of infections. The global market is primarily supported by fundamental drivers such as the escalating prevalence of sexually transmitted diseases and rigorous government initiatives aimed at family planning. These factors create a sustained structural demand for affordable prophylactic solutions that operates independently of temporary consumer trends, ensuring a baseline requirement for disease prevention products across international healthcare systems.

However, the sector faces a significant challenge regarding the reduction in international funding and procurement which impedes broad distribution in critical regions. According to the Joint United Nations Programme on HIV/AIDS, in 2025, estimated global public sector condom procurement declined by an average of 30 percent from peak levels recorded in 2011. This contraction in subsidized availability constitutes a substantial hurdle to market volume expansion, particularly in developing economies that remain heavily reliant on donor-funded sexual health programs for consistent supply.

Key Market Drivers

The rising global incidence of sexually transmitted infections (STIs) and HIV serves as a primary catalyst for the condom market, necessitating sustained manufacturing output to meet public health requirements. As infection rates climb, health agencies prioritize barrier methods as the first line of defense, thereby securing consistent market volume independent of commercial cycles. According to The Global Fund to Fight AIDS, Tuberculosis and Malaria, September 2025, in the 'Results Report 2025', there were 1.3 million new HIV infections recorded globally in 2024, underscoring the critical need for continued prophylactic accessibility. This trend is further evidenced in developed nations where treatable infections remain persistent; according to HIV.gov, in 2025, provisional surveillance data indicated that more than 2.2 million cases of chlamydia, gonorrhea, and syphilis were reported in the United States in 2024. Consequently, the market is structurally underpinned by the urgent necessity to curb these transmission vectors through widespread product availability.

Government-led initiatives for family planning and disease prevention function as the second major driver, effectively stabilizing demand through large-scale institutional procurement programs. National health departments and international bodies actively subsidize or freely distribute prophylactics to high-risk populations, creating a reliable volume channel for manufacturers that offsets volatility in the private retail sector. These programs are particularly aggressive in regions battling high disease burdens, where state intervention directly translates to massive unit consumption. For instance, according to the Uganda AIDS Commission, December 2025, in the 'Uganda Scores 97% HIV Suppression' report, the public sector distribution of male condoms increased to approximately 207.9 million units in 2024. Such extensive public sector commitments ensure that despite funding fluctuations, the core industrial output remains engaged to fulfill these mandate-driven supply chains.

Download Free Sample Report

Key Market Challenges

The reduction in international funding and procurement presents a critical obstacle to the expansion of the Global Condom Market. This financial contraction directly impacts the volume of products distributed in developing regions, where market growth is heavily dependent on subsidized bulk purchasing by global health bodies. When donor contributions stagnate or decline, the supply chain fractures, leading to immediate stock shortages in high-demand areas that lack the economic capacity to shift toward commercial retail purchasing. Consequently, manufacturers face unpredictable order volumes, which disrupts production planning and hampers revenue stability.

This reliance on external aid creates a fragile market ecosystem susceptible to budgetary deficits. The inability to secure consistent financing restricts the reach of prevention programs, effectively capping market volume. According to the Global Fund, in 2024, decreasing international funding posed a serious threat to disease prevention progress, contributing to a scenario where 1.3 million new HIV infections were recorded globally. This correlation highlights how funding gaps directly translate to reduced product accessibility and market stagnation, preventing the industry from reaching its full potential in emerging economies.

Key Market Trends

The diversification of pleasure-enhancing textures and formulations is fundamentally reshaping the market by transitioning consumer focus from basic prophylactic utility to sexual wellness and experiential satisfaction. Manufacturers are increasingly engineering products with stimulating ribs, dots, and desensitizing lubricants to attract a premium clientele that operates outside the price-sensitive public sector. This strategy effectively insulates brands from commodity pricing pressures by marketing condoms as lifestyle products rather than medical necessities. According to Reckitt Benckiser Group plc, October 2025, in the 'Q3 2025 Trading Update', the company recorded double-digit growth in its Intimate Wellness category within emerging markets, specifically driven by the rapid uptake of new performance-focused innovations such as Benzocaine-infused condoms.

Simultaneously, there is a distinct shift toward direct-to-consumer and subscription-based retail models which circumvents the volatility associated with international donor funding. While institutional procurement faces budgetary constraints, the private retail segment is expanding as brands establish direct relationships with users through e-commerce and physical retail partnerships that emphasize brand loyalty and consistent availability. This commercial robustness provides a counterweight to the declining government tender volumes, ensuring revenue stability through recurring private purchases. According to Church & Dwight Co., Inc., October 2025, in the 'Q3 2025 Earnings Press Release', the company's domestic organic sales grew by 2.3 percent, a performance primarily led by the sustained retail demand for its premium Trojan condom portfolio.

Segmental Insights

The Latex Condom segment represents the fastest growing category in the Global Condom Market, driven by its unmatched combination of affordability and reliability. This segment benefits significantly from extensive adoption in public health programs, where institutions such as the World Health Organization advocate for latex products to combat the spread of sexually transmitted infections. The high efficacy of natural rubber latex in barrier protection fosters strong consumer trust, while its low production cost supports mass distribution across emerging economies. These factors, combined with continuous improvements in product thinness and comfort, fuel the segment’s rapid expansion.

Regional Insights

Asia Pacific maintains a dominant position in the global condom market, driven primarily by the substantial population base in key economies like China and India. This leadership is sustained by extensive government initiatives focused on family planning and the prevention of sexually transmitted infections. For example, large-scale procurement programs by institutions such as India’s Ministry of Health and Family Welfare ensure widespread product availability through subsidized distribution. Additionally, rising urbanization and growing awareness regarding reproductive health continue to accelerate commercial demand, solidifying the region’s status as the principal market for manufacturers.

Recent Developments

• In December 2025, Reckitt and DKSH finalized an expansion of their strategic partnership to strengthen the distribution of consumer health products across Malaysia. Under the terms of the agreement, DKSH was appointed to manage market expansion services, including sales, merchandising, and logistics, for a portfolio of brands that includes Durex. This collaboration specifically targeted the medical and independent pharmacy channels to ensure broader product availability and commercial excellence. The move was described as a key step in Reckitt's strategy to optimize its regional operations and improve access to its sexual wellness and hygiene solutions in the Southeast Asian market.
• In May 2025, LifeStyles Healthcare, through its SKYN brand, introduced SKYN KING, a new line of large-sized non-latex condoms in the North American market. Utilizing the company’s proprietary polyisoprene material, the product was developed to provide a softer, more natural fit for users who require larger dimensions, addressing a gap in the non-latex segment. The product debut was accompanied by a brand campaign that challenged traditional narratives around masculinity and encouraged consumers to prioritize comfort. The Chief Executive Officer stated that this expansion reflected the company's dedication to inclusivity and its ability to adapt to the diverse physical needs of its global customer base.
• In September 2024, Durex announced a significant innovation for the South Asian market with the release of the Close Fit Invisible Condom. Marketed as the region's first ultra-thin condom with a close-fit design, the product was engineered to address specific consumer concerns regarding fit, slippage, and sensitivity. The launch was strategically positioned to drive category adoption by offering a solution that balanced high safety standards with an enhanced "second skin" sensation. A regional marketing director for the company noted that the product aimed to overcome mental barriers associated with condom use by proving that protection does not require compromising on intimacy.
• In May 2024, Mankind Pharma expanded its premium product portfolio in the Indian market with the launch of the Epic ThinX Condom. This new offering, measuring just 0.03 mm in thickness, was marketed as a vegan, chemical-free solution designed to enhance sensitivity and provide a natural feel. To support the product introduction, the company executed a comprehensive marketing campaign aimed at empowering women to take an active role in selecting sexual wellness products. The Managing Director emphasized that the initiative sought to shift consumer mindsets by highlighting that decisions regarding protection and pleasure should be a shared responsibility between partners.

Key Market Players

• Okamoto Industries, Inc.
• Cupid Limited
• Reckitt Benckiser Group
• Karex Berhad
• Church & Dwight Co., Inc.
• Fuji Latex Co., Ltd.
• Leloi AB
• LifeStyles Healthcare Pte Ltd.
• Veru, Inc.
• Mayer Laboratories, Inc.

By Gender	By Type	By Distribution Channel	By Region
Male Female	Latex Condom Non-Latex Condom	Supermarkets/Hypermarkets Drug/Pharmacy Stores Convenience Stores Online Others (Departmental Stores, etc.)	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Condom Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Condom Market, By Gender:

• Male
• Female

• Condom Market, By Type:

• Latex Condom
• Non-Latex Condom

• Condom Market, By Distribution Channel:

• Supermarkets/Hypermarkets
• Drug/Pharmacy Stores
• Convenience Stores
• Online
• Others (Departmental Stores, etc.)

• Condom Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE